MEDICAMA
ActiveMEDICAMA has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €419k and a net result of €52k. Equity is growing by ~16.8% per year across the filed fiscal years. Its solvency ranks better than 93% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
97
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability84▼-2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 25.24 against 26.37 in 2024; short-term debt: 3.8% and cash: 47.1% of total assets), and 3.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
96.2%
Return on assets
11.8%
Age of the figures
11 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-10-2025 was due by 31-05-2026 and was filed on 01-04-2026, 60 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
60 d early
2024
75 d early
2023
85 d early
2022
69 d early
2021
64 d early
2020
40 d early
2019
68 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-10-2026 and is due by 31-05-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-10-2026 close31-05-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€419k▲ 13.8%
2024 · €368k
2018: €143k
2019: €175k
2020: €174k
2021: €239k
2022: €288k
2023: €325k
2024: €368k
2018 → 2025
Total assets
€436k▲ 14.1%
2024 · €382k
2018: €148k
2019: €177k
2020: €199k
2021: €252k
2022: €300k
2023: €328k
2024: €382k
2018 → 2025
Net result
€52k▼ 3.2%
2024 · €53k
2018: €17k
2019: €32k
2020: €29k
2021: €65k
2022: €49k
2023: €37k
2024: €53k
2018 → 2025
Working capital
€401k▲ 17.0%
2024 · €343k
2018: €91k
2019: €139k
2020: €152k
2021: €192k
2022: €247k
2023: €289k
2024: €343k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€239k-€288k▲ 20.6%€325k▲ 13.0%€368k▲ 13.3%€419k▲ 13.8%
Operating result€97k-€86k▼ 11.3%€56k▼ 35.1%€76k▲ 36.2%€70k▼ 8.1%
Net result€65k-€49k▼ 24.0%€37k▼ 23.8%€53k▲ 42.2%€52k▼ 3.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €436k
Fixed assets
€18k▼ 29.0%
Current assets
€417k▲ 17.2%
Equity and liabilities €436k
Equity
€419k▲ 13.8%
Debt
€17k▲ 22.5%
The debt ratio rises from 3.5% to 3.8%. Equity and debt are higher.
Key figures and ratios
EBITDA
€80k▼
2024 · €86k
Cash flow
€62k▼
2024 · €64k
Solvency
96.2%▼
2024 · 96.5%
Current ratio
25.24▼
2024 · 26.37
Quick ratio
25.24▼
2024 · 26.37
Debt / equity
0.04▲
2024 · 0.04
ROE
12.3%▼
2024 · 14.4%
ROA
11.8%▼
2024 · 13.9%
Interest coverage
1665.29▼
2024 · 1753.13
Debt
€17k▲
2024 · €14k
Debt ≤ 1 year
€17k▲
2024 · €14k
Income taxes
€26k▼
2024 · €27k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€382k€436k▲
Fixed assets21/28€26k€18k▼
Tangible fixed assets22/27€26k€18k▼
Land and buildings22€8k€7k▼
Furniture and vehicles24€15k€9k▼
Other tangible fixed assets26€3k€2k▼
Current assets29/58€356k€417k▲
Current investments50/53€200k€200k=
Cash at bank and in hand54/58€139k€205k▲
Deferred charges and accrued income490/1€17k€12k▼
Equity and liabilities
Total equity and liabilities10/49€382k€436k▲
Equity10/15€368k€419k▲
Contributions10/11€12k€12k=
Reserves13€339k€390k▲
Distributable reserves133€339k€390k▲
Profit (loss) carried forward14€17k€16k▼
Amounts payable17/49€14k€17k▲
Amounts payable within one year42/48€14k€17k▲
Trade debts44€711€820▲
Suppliers440/4€711€820▲
Taxes, remuneration and social security45€7k€6k▼
Taxes450/3€7k€6k▼
Other amounts payable47/48€5k€9k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€10k▼
Other operating charges640/8€1k€705▼
Gross operating margin9900€88k€81k▼
Operating profit (loss)9901€76k€70k▼
Financial income75/76B€4k€8k▲
Recurring financial income75€4k€8k▲
Financial charges65/66B€49€48▼
Recurring financial charges65€49€48▼
Profit (loss) for the period before taxes9903€80k€78k▼
Income taxes67/77€27k€26k▼
Profit (loss) for the period9904€53k€52k▼
Profit (loss) for the period to be appropriated9905€53k€52k▼
Appropriation of the result
Profit (loss) to be appropriated9906€71k€69k▼
Profit (loss) brought forward from the previous period14P€17k€17k=
Transfer from equity791/2€10k-
Transfer to equity691/2€53k€52k▼
To other reserves6921€53k€52k▼
Profit to be distributed694/7€10k€833▼
Return on contributions (dividend)694€10k€833▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
17-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
07-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-10
Financial
Liquidity times 6current ratio 124.04
Current ratio from 21.85 to 124.04; short-term debt falls from €12k to €2k.
23-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
28-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-10
Financial
Highest result since 2018net €65k ▲124%
Operating result €97k, net result €65k, both a record.
31-10
Financial
Liquidity doublescurrent ratio 15.15
Current ratio from 6.99 to 15.15; short-term debt falls from €25k to €14k.
31-10
Financial
Equity above €200kEq €239k ▲37.1%
4 profitable years in a row build equity to €239k.
21-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
24-03
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-10
Financial
Liquidity triplescurrent ratio 58.40
Current ratio from 17.83 to 58.40; short-term debt falls from €5k to €2k.
31-10
Financial
Equity above €150kEq €175k ▲22.4%
2 profitable years in a row build equity to €175k.
02-04
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
01-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 1 day late
2017
13-04
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2010
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
30-09-2010
Resigned as Managing director
Location & real-estate footprint
Registered office, Saint-Ghislain
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Fosty(B) 67331 Saint-GhislainGround area
1,017 m²
Building footprint
122 m²
Parcel 53009E0121/00G003, Wallonia. Linked by address, not a title deed.
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53009E0121/00G003 | Wallonia | 1,017 m² | 1 · 122 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
699400O3IQIBTW6NAS72
Similar companies · same sector, comparable size
Chiropractor Gent
BE 1003.135.495
Gent · Eq €419k
DRS. HARDY
BE 0473.463.532
Riemst · Eq €419k
Dr. Emilie Deroy
BE 0540.699.180
Turnhout · Eq €419k
CLAERHOUT G.
BE 0480.256.403
Kortrijk · Eq €419k
OPHTARA
BE 0879.261.349
Brussel · Eq €419k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,031 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-12-1989
Fiscal year end31-10
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 36 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.